Comments on: CD19-CD22 CAR-T cells by Shanghai Biomed-Union Biotechnology for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval /data-insights/cd19-cd22-car-t-cells-shanghai-biomed-union-biotechnology-b-cell-acute-lymphocytic-leukemia-b-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Thu, 04 Jan 2024 23:58:02 +0000 hourly 1 https://wordpress.org/?v=6.7.1